Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. (Q42220049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

Pallavi Mandal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Catriona Graham

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Catherine Harley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Manjit K Sidhu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Catherine Doherty

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

John W Govan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Tariq Sethi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Adriano G Rossi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Adam T Hill

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

24 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

13 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

455-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

Bronchiectasis: breaking the cycle of inflammation and infection.

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Systemic markers of inflammation in stable bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Anti-inflammatory Agents: Present and Future

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statins enhance formation of phagocyte extracellular traps

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Simvastatin is protective during Staphylococcus aureus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Prior statin use is associated with improved outcomes in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Development of a shuttle walking test of disability in patients with chronic airways obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Validation of the St. George's Respiratory Questionnaire in bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

The chemotactic activity of sputum from patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Induced sputum to assess airway inflammation: a study of reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

The interrelationship of sputum inflammatory markers in patients with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Validation of assays for inflammatory mediators in sputum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

British Thoracic Society guideline for non-CF bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statin use and risk of COPD exacerbation requiring hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statins, systemic inflammation and risk of death in COPD: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Graft-protective effects of the HMG-CoA reductase inhibitor pravastatin after lung transplantation--a propensity score analysis with 23 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statins for the prevention and treatment of infections: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Modulation of Brain Injury as a Target of Adjunctive Therapy in Bacterial Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statins, Bcl-2, and apoptosis: cell death or cell protection?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Statin treatment after onset of sepsis in a murine model improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Lovastatin Enhances Clearance of Apoptotic Cells (Efferocytosis) with Implications for Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2814%2970050-5

7 January 2021

10.1016/S2213-2600(14)70050-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717640%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference